Document is current
Any future updates will be listed below
-
Authors
Sebastian, Michael https://orcid.org/0000-0003-4082-6977
Bagel, Jerry
Hoepken, Bengt
Knapp, Bertram
Bicer, Ceyhun
MacPherson, Merran
Langley, Richard G.
-
Funding
Funding for this research was provided by:
UCB
- License Information
-
More Information
Article History
Received: 22 December 2024
Accepted: 14 February 2025
First Online: 29 March 2025
Declarations
:
: Michael Sebastian: Cooperations with the following companies: AbbVie, Affibody, Allergan, Alumis, Almirall, Apogee, AstraZeneca, August Wolff, Boehringer Ingelheim, Bristol Myers Squibb, Dermapharm, Dermira, Galderma, Incyte, Ipsen, Janssen-Cilag, LEO Pharma, MedImmune, Menlo Therapeutics, Moonlake, MSD, Mundipharma, Novartis, Pfizer, Regeneron, Sanofi, Takeda, and UCB Pharma; Jerry Bagel: Speaker, investigator and/or consultant for AbbVie, Celgene, Eli Lilly and Company, LEO Pharma, Novartis, Ortho Dermatologics; research funds payable to Psoriasis Treatment Center from AbbVie, Amgen, Arcutis Biotherapeutics, Boehringer Ingelheim, Bristol Myers Squibb, Celgene, CorEvitas, Dermavant Sciences, Dermira, Eli Lilly and Company, Glenmark Pharmaceuticals, Janssen, Kadmon Corporation, LEO Pharma, Lycera, Menlo Therapeutics, Novartis, Ortho Dermatologics, Pfizer, Regeneron, Sun Pharma, Taro, and UCB; consultant fees from AbbVie, Amgen, Bristol Myers Squibb, Celgene, Eli Lilly and Company, Janssen, Novartis, Sun Pharma, and UCB; and fees for speaking from AbbVie, Celgene, Eli Lilly and Company, Janssen, and Novartis; Bengt Hoepken, Bertram Knapp, Merran MacPherson: employees of UCB; Ceyhun Bicer: statistical consultant at UCB; Richard G. Langley: Principal investigator for AbbVie, Amgen, Boehringer Ingelheim, Celgene, Eli Lilly, LEO Pharma, Merck, Novartis, Pfizer, and UCB Pharma; served on scientific advisory boards for AbbVie, Amgen, Boehringer Ingelheim, Celgene, Eli Lilly, LEO Pharma, Merck, Novartis, Pfizer, and UCB Pharma; provided lectures for AbbVie, Amgen, Celgene, Eli Lilly, LEO Pharma, Merck, Novartis, and Pfizer.
: All studies were conducted in accordance with the principles of the Declaration of Helsinki and were approved by an independent review board and independent ethics committee. All participants provided informed written consent. All the results presented in this article are in aggregate form, and no personally identifiable information was used for this study.
